0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gastrodia Capsules Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-24E16682
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Gastrodia Capsules Market Research Report 2024
BUY CHAPTERS

Global Gastrodia Capsules Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-24E16682
Report
November 2025
Pages:185
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Gastrodia Capsules Market

The global Gastrodia Capsules market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Gastrodia Capsules leading manufacturers including Hefei Jinyue Pharmaceutical Co., Ltd., Tonghua Xindongri Pharmaceutical Co., Ltd., Jilin Haitong Pharmaceutical Co., Ltd., Jilin Jichun Pharmaceutical Co., Ltd., Huatuo Sinopharm Co., Ltd., Tonghua Jitong Pharmaceutical Co., Ltd., Tonghua Yongji Pharmaceutical Co., Ltd., Tonghua Aixin Pharmaceutical Co., Ltd., Changbaishan Pharmaceutical Co., Ltd., Anshan Pharmaceutical Co., Ltd., etc., dominate supply; the top five capture approximately % of global revenue, with Hefei Jinyue Pharmaceutical Co., Ltd. leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Gastrodia Capsules market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Gastrodia Capsules Market Report

Report Metric Details
Report Name Gastrodia Capsules Market
Segment by Type
  • 0.25g Per Capsule
  • 0.5g Per Capsule
Segment by Application
  • Hospital
  • Clinic
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Hefei Jinyue Pharmaceutical Co., Ltd., Tonghua Xindongri Pharmaceutical Co., Ltd., Jilin Haitong Pharmaceutical Co., Ltd., Jilin Jichun Pharmaceutical Co., Ltd., Huatuo Sinopharm Co., Ltd., Tonghua Jitong Pharmaceutical Co., Ltd., Tonghua Yongji Pharmaceutical Co., Ltd., Tonghua Aixin Pharmaceutical Co., Ltd., Changbaishan Pharmaceutical Co., Ltd., Anshan Pharmaceutical Co., Ltd., Revised Pharmaceutical Group Co., Ltd., Jilin Luwang Pharmaceutical Co., Ltd., Shanxi Wanglong Pharmaceutical Group Co., Ltd., Suzhou Huabao Pharmaceutical Co., Ltd., Jilin Zixin Pharmaceutical Co., Ltd., Harbin Traditional Chinese Medicine No.4 Co., Ltd., Jilin Changbaishan Pharmaceutical Group Co., Ltd., Tonghua Dongsheng Pharmaceutical Co., Ltd., Yaodu Pharmaceutical Group Co., Ltd., Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory, Jilin Sinopharm Pharmaceutical Co., Ltd., Jilin Fusong Pharmaceutical Co., Ltd., Liaoning Deshan Pharmaceutical Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Gastrodia Capsules study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Gastrodia Capsules Market report?

Ans: The main players in the Gastrodia Capsules Market are Hefei Jinyue Pharmaceutical Co., Ltd., Tonghua Xindongri Pharmaceutical Co., Ltd., Jilin Haitong Pharmaceutical Co., Ltd., Jilin Jichun Pharmaceutical Co., Ltd., Huatuo Sinopharm Co., Ltd., Tonghua Jitong Pharmaceutical Co., Ltd., Tonghua Yongji Pharmaceutical Co., Ltd., Tonghua Aixin Pharmaceutical Co., Ltd., Changbaishan Pharmaceutical Co., Ltd., Anshan Pharmaceutical Co., Ltd., Revised Pharmaceutical Group Co., Ltd., Jilin Luwang Pharmaceutical Co., Ltd., Shanxi Wanglong Pharmaceutical Group Co., Ltd., Suzhou Huabao Pharmaceutical Co., Ltd., Jilin Zixin Pharmaceutical Co., Ltd., Harbin Traditional Chinese Medicine No.4 Co., Ltd., Jilin Changbaishan Pharmaceutical Group Co., Ltd., Tonghua Dongsheng Pharmaceutical Co., Ltd., Yaodu Pharmaceutical Group Co., Ltd., Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory, Jilin Sinopharm Pharmaceutical Co., Ltd., Jilin Fusong Pharmaceutical Co., Ltd., Liaoning Deshan Pharmaceutical Co., Ltd.

What are the Application segmentation covered in the Gastrodia Capsules Market report?

Ans: The Applications covered in the Gastrodia Capsules Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Gastrodia Capsules Market report?

Ans: The Types covered in the Gastrodia Capsules Market report are 0.25g Per Capsule, 0.5g Per Capsule

1 Study Coverage
1.1 Introduction to Gastrodia Capsules: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Gastrodia Capsules Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 0.25g Per Capsule
1.2.3 0.5g Per Capsule
1.3 Market Segmentation by Application
1.3.1 Global Gastrodia Capsules Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gastrodia Capsules Revenue Estimates and Forecasts 2020-2031
2.2 Global Gastrodia Capsules Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Gastrodia Capsules Sales Estimates and Forecasts 2020-2031
2.4 Global Gastrodia Capsules Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Gastrodia Capsules Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Gastrodia Capsules Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 0.25g Per Capsule Market Size by Manufacturers
3.5.2 0.5g Per Capsule Market Size by Manufacturers
3.6 Global Gastrodia Capsules Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Gastrodia Capsules Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Gastrodia Capsules Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Gastrodia Capsules Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Gastrodia Capsules Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Gastrodia Capsules Sales and Revenue by Type (2020-2031)
6.4 North America Gastrodia Capsules Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Gastrodia Capsules Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Gastrodia Capsules Sales and Revenue by Type (2020-2031)
7.4 Europe Gastrodia Capsules Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Gastrodia Capsules Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Gastrodia Capsules Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Gastrodia Capsules Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Gastrodia Capsules Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Gastrodia Capsules Sales and Revenue by Type (2020-2031)
9.4 Central and South America Gastrodia Capsules Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Gastrodia Capsules Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Gastrodia Capsules Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Gastrodia Capsules Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Gastrodia Capsules Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Hefei Jinyue Pharmaceutical Co., Ltd.
11.1.1 Hefei Jinyue Pharmaceutical Co., Ltd. Corporation Information
11.1.2 Hefei Jinyue Pharmaceutical Co., Ltd. Business Overview
11.1.3 Hefei Jinyue Pharmaceutical Co., Ltd. Gastrodia Capsules Product Models, Descriptions and Specifications
11.1.4 Hefei Jinyue Pharmaceutical Co., Ltd. Gastrodia Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Hefei Jinyue Pharmaceutical Co., Ltd. Gastrodia Capsules Sales by Product in 2024
11.1.6 Hefei Jinyue Pharmaceutical Co., Ltd. Gastrodia Capsules Sales by Application in 2024
11.1.7 Hefei Jinyue Pharmaceutical Co., Ltd. Gastrodia Capsules Sales by Geographic Area in 2024
11.1.8 Hefei Jinyue Pharmaceutical Co., Ltd. Gastrodia Capsules SWOT Analysis
11.1.9 Hefei Jinyue Pharmaceutical Co., Ltd. Recent Developments
11.2 Tonghua Xindongri Pharmaceutical Co., Ltd.
11.2.1 Tonghua Xindongri Pharmaceutical Co., Ltd. Corporation Information
11.2.2 Tonghua Xindongri Pharmaceutical Co., Ltd. Business Overview
11.2.3 Tonghua Xindongri Pharmaceutical Co., Ltd. Gastrodia Capsules Product Models, Descriptions and Specifications
11.2.4 Tonghua Xindongri Pharmaceutical Co., Ltd. Gastrodia Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Tonghua Xindongri Pharmaceutical Co., Ltd. Gastrodia Capsules Sales by Product in 2024
11.2.6 Tonghua Xindongri Pharmaceutical Co., Ltd. Gastrodia Capsules Sales by Application in 2024
11.2.7 Tonghua Xindongri Pharmaceutical Co., Ltd. Gastrodia Capsules Sales by Geographic Area in 2024
11.2.8 Tonghua Xindongri Pharmaceutical Co., Ltd. Gastrodia Capsules SWOT Analysis
11.2.9 Tonghua Xindongri Pharmaceutical Co., Ltd. Recent Developments
11.3 Jilin Haitong Pharmaceutical Co., Ltd.
11.3.1 Jilin Haitong Pharmaceutical Co., Ltd. Corporation Information
11.3.2 Jilin Haitong Pharmaceutical Co., Ltd. Business Overview
11.3.3 Jilin Haitong Pharmaceutical Co., Ltd. Gastrodia Capsules Product Models, Descriptions and Specifications
11.3.4 Jilin Haitong Pharmaceutical Co., Ltd. Gastrodia Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Jilin Haitong Pharmaceutical Co., Ltd. Gastrodia Capsules Sales by Product in 2024
11.3.6 Jilin Haitong Pharmaceutical Co., Ltd. Gastrodia Capsules Sales by Application in 2024
11.3.7 Jilin Haitong Pharmaceutical Co., Ltd. Gastrodia Capsules Sales by Geographic Area in 2024
11.3.8 Jilin Haitong Pharmaceutical Co., Ltd. Gastrodia Capsules SWOT Analysis
11.3.9 Jilin Haitong Pharmaceutical Co., Ltd. Recent Developments
11.4 Jilin Jichun Pharmaceutical Co., Ltd.
11.4.1 Jilin Jichun Pharmaceutical Co., Ltd. Corporation Information
11.4.2 Jilin Jichun Pharmaceutical Co., Ltd. Business Overview
11.4.3 Jilin Jichun Pharmaceutical Co., Ltd. Gastrodia Capsules Product Models, Descriptions and Specifications
11.4.4 Jilin Jichun Pharmaceutical Co., Ltd. Gastrodia Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Jilin Jichun Pharmaceutical Co., Ltd. Gastrodia Capsules Sales by Product in 2024
11.4.6 Jilin Jichun Pharmaceutical Co., Ltd. Gastrodia Capsules Sales by Application in 2024
11.4.7 Jilin Jichun Pharmaceutical Co., Ltd. Gastrodia Capsules Sales by Geographic Area in 2024
11.4.8 Jilin Jichun Pharmaceutical Co., Ltd. Gastrodia Capsules SWOT Analysis
11.4.9 Jilin Jichun Pharmaceutical Co., Ltd. Recent Developments
11.5 Huatuo Sinopharm Co., Ltd.
11.5.1 Huatuo Sinopharm Co., Ltd. Corporation Information
11.5.2 Huatuo Sinopharm Co., Ltd. Business Overview
11.5.3 Huatuo Sinopharm Co., Ltd. Gastrodia Capsules Product Models, Descriptions and Specifications
11.5.4 Huatuo Sinopharm Co., Ltd. Gastrodia Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Huatuo Sinopharm Co., Ltd. Gastrodia Capsules Sales by Product in 2024
11.5.6 Huatuo Sinopharm Co., Ltd. Gastrodia Capsules Sales by Application in 2024
11.5.7 Huatuo Sinopharm Co., Ltd. Gastrodia Capsules Sales by Geographic Area in 2024
11.5.8 Huatuo Sinopharm Co., Ltd. Gastrodia Capsules SWOT Analysis
11.5.9 Huatuo Sinopharm Co., Ltd. Recent Developments
11.6 Tonghua Jitong Pharmaceutical Co., Ltd.
11.6.1 Tonghua Jitong Pharmaceutical Co., Ltd. Corporation Information
11.6.2 Tonghua Jitong Pharmaceutical Co., Ltd. Business Overview
11.6.3 Tonghua Jitong Pharmaceutical Co., Ltd. Gastrodia Capsules Product Models, Descriptions and Specifications
11.6.4 Tonghua Jitong Pharmaceutical Co., Ltd. Gastrodia Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Tonghua Jitong Pharmaceutical Co., Ltd. Recent Developments
11.7 Tonghua Yongji Pharmaceutical Co., Ltd.
11.7.1 Tonghua Yongji Pharmaceutical Co., Ltd. Corporation Information
11.7.2 Tonghua Yongji Pharmaceutical Co., Ltd. Business Overview
11.7.3 Tonghua Yongji Pharmaceutical Co., Ltd. Gastrodia Capsules Product Models, Descriptions and Specifications
11.7.4 Tonghua Yongji Pharmaceutical Co., Ltd. Gastrodia Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Tonghua Yongji Pharmaceutical Co., Ltd. Recent Developments
11.8 Tonghua Aixin Pharmaceutical Co., Ltd.
11.8.1 Tonghua Aixin Pharmaceutical Co., Ltd. Corporation Information
11.8.2 Tonghua Aixin Pharmaceutical Co., Ltd. Business Overview
11.8.3 Tonghua Aixin Pharmaceutical Co., Ltd. Gastrodia Capsules Product Models, Descriptions and Specifications
11.8.4 Tonghua Aixin Pharmaceutical Co., Ltd. Gastrodia Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Tonghua Aixin Pharmaceutical Co., Ltd. Recent Developments
11.9 Changbaishan Pharmaceutical Co., Ltd.
11.9.1 Changbaishan Pharmaceutical Co., Ltd. Corporation Information
11.9.2 Changbaishan Pharmaceutical Co., Ltd. Business Overview
11.9.3 Changbaishan Pharmaceutical Co., Ltd. Gastrodia Capsules Product Models, Descriptions and Specifications
11.9.4 Changbaishan Pharmaceutical Co., Ltd. Gastrodia Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Changbaishan Pharmaceutical Co., Ltd. Recent Developments
11.10 Anshan Pharmaceutical Co., Ltd.
11.10.1 Anshan Pharmaceutical Co., Ltd. Corporation Information
11.10.2 Anshan Pharmaceutical Co., Ltd. Business Overview
11.10.3 Anshan Pharmaceutical Co., Ltd. Gastrodia Capsules Product Models, Descriptions and Specifications
11.10.4 Anshan Pharmaceutical Co., Ltd. Gastrodia Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Anshan Pharmaceutical Co., Ltd. Recent Developments
11.11 Revised Pharmaceutical Group Co., Ltd.
11.11.1 Revised Pharmaceutical Group Co., Ltd. Corporation Information
11.11.2 Revised Pharmaceutical Group Co., Ltd. Business Overview
11.11.3 Revised Pharmaceutical Group Co., Ltd. Gastrodia Capsules Product Models, Descriptions and Specifications
11.11.4 Revised Pharmaceutical Group Co., Ltd. Gastrodia Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Revised Pharmaceutical Group Co., Ltd. Recent Developments
11.12 Jilin Luwang Pharmaceutical Co., Ltd.
11.12.1 Jilin Luwang Pharmaceutical Co., Ltd. Corporation Information
11.12.2 Jilin Luwang Pharmaceutical Co., Ltd. Business Overview
11.12.3 Jilin Luwang Pharmaceutical Co., Ltd. Gastrodia Capsules Product Models, Descriptions and Specifications
11.12.4 Jilin Luwang Pharmaceutical Co., Ltd. Gastrodia Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Jilin Luwang Pharmaceutical Co., Ltd. Recent Developments
11.13 Shanxi Wanglong Pharmaceutical Group Co., Ltd.
11.13.1 Shanxi Wanglong Pharmaceutical Group Co., Ltd. Corporation Information
11.13.2 Shanxi Wanglong Pharmaceutical Group Co., Ltd. Business Overview
11.13.3 Shanxi Wanglong Pharmaceutical Group Co., Ltd. Gastrodia Capsules Product Models, Descriptions and Specifications
11.13.4 Shanxi Wanglong Pharmaceutical Group Co., Ltd. Gastrodia Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Shanxi Wanglong Pharmaceutical Group Co., Ltd. Recent Developments
11.14 Suzhou Huabao Pharmaceutical Co., Ltd.
11.14.1 Suzhou Huabao Pharmaceutical Co., Ltd. Corporation Information
11.14.2 Suzhou Huabao Pharmaceutical Co., Ltd. Business Overview
11.14.3 Suzhou Huabao Pharmaceutical Co., Ltd. Gastrodia Capsules Product Models, Descriptions and Specifications
11.14.4 Suzhou Huabao Pharmaceutical Co., Ltd. Gastrodia Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Suzhou Huabao Pharmaceutical Co., Ltd. Recent Developments
11.15 Jilin Zixin Pharmaceutical Co., Ltd.
11.15.1 Jilin Zixin Pharmaceutical Co., Ltd. Corporation Information
11.15.2 Jilin Zixin Pharmaceutical Co., Ltd. Business Overview
11.15.3 Jilin Zixin Pharmaceutical Co., Ltd. Gastrodia Capsules Product Models, Descriptions and Specifications
11.15.4 Jilin Zixin Pharmaceutical Co., Ltd. Gastrodia Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Jilin Zixin Pharmaceutical Co., Ltd. Recent Developments
11.16 Harbin Traditional Chinese Medicine No.4 Co., Ltd.
11.16.1 Harbin Traditional Chinese Medicine No.4 Co., Ltd. Corporation Information
11.16.2 Harbin Traditional Chinese Medicine No.4 Co., Ltd. Business Overview
11.16.3 Harbin Traditional Chinese Medicine No.4 Co., Ltd. Gastrodia Capsules Product Models, Descriptions and Specifications
11.16.4 Harbin Traditional Chinese Medicine No.4 Co., Ltd. Gastrodia Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Harbin Traditional Chinese Medicine No.4 Co., Ltd. Recent Developments
11.17 Jilin Changbaishan Pharmaceutical Group Co., Ltd.
11.17.1 Jilin Changbaishan Pharmaceutical Group Co., Ltd. Corporation Information
11.17.2 Jilin Changbaishan Pharmaceutical Group Co., Ltd. Business Overview
11.17.3 Jilin Changbaishan Pharmaceutical Group Co., Ltd. Gastrodia Capsules Product Models, Descriptions and Specifications
11.17.4 Jilin Changbaishan Pharmaceutical Group Co., Ltd. Gastrodia Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Jilin Changbaishan Pharmaceutical Group Co., Ltd. Recent Developments
11.18 Tonghua Dongsheng Pharmaceutical Co., Ltd.
11.18.1 Tonghua Dongsheng Pharmaceutical Co., Ltd. Corporation Information
11.18.2 Tonghua Dongsheng Pharmaceutical Co., Ltd. Business Overview
11.18.3 Tonghua Dongsheng Pharmaceutical Co., Ltd. Gastrodia Capsules Product Models, Descriptions and Specifications
11.18.4 Tonghua Dongsheng Pharmaceutical Co., Ltd. Gastrodia Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Tonghua Dongsheng Pharmaceutical Co., Ltd. Recent Developments
11.19 Yaodu Pharmaceutical Group Co., Ltd.
11.19.1 Yaodu Pharmaceutical Group Co., Ltd. Corporation Information
11.19.2 Yaodu Pharmaceutical Group Co., Ltd. Business Overview
11.19.3 Yaodu Pharmaceutical Group Co., Ltd. Gastrodia Capsules Product Models, Descriptions and Specifications
11.19.4 Yaodu Pharmaceutical Group Co., Ltd. Gastrodia Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Yaodu Pharmaceutical Group Co., Ltd. Recent Developments
11.20 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory
11.20.1 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Corporation Information
11.20.2 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Business Overview
11.20.3 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Gastrodia Capsules Product Models, Descriptions and Specifications
11.20.4 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Gastrodia Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Recent Developments
11.21 Jilin Sinopharm Pharmaceutical Co., Ltd.
11.21.1 Jilin Sinopharm Pharmaceutical Co., Ltd. Corporation Information
11.21.2 Jilin Sinopharm Pharmaceutical Co., Ltd. Business Overview
11.21.3 Jilin Sinopharm Pharmaceutical Co., Ltd. Gastrodia Capsules Product Models, Descriptions and Specifications
11.21.4 Jilin Sinopharm Pharmaceutical Co., Ltd. Gastrodia Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.21.5 Jilin Sinopharm Pharmaceutical Co., Ltd. Recent Developments
11.22 Jilin Fusong Pharmaceutical Co., Ltd.
11.22.1 Jilin Fusong Pharmaceutical Co., Ltd. Corporation Information
11.22.2 Jilin Fusong Pharmaceutical Co., Ltd. Business Overview
11.22.3 Jilin Fusong Pharmaceutical Co., Ltd. Gastrodia Capsules Product Models, Descriptions and Specifications
11.22.4 Jilin Fusong Pharmaceutical Co., Ltd. Gastrodia Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.22.5 Jilin Fusong Pharmaceutical Co., Ltd. Recent Developments
11.23 Liaoning Deshan Pharmaceutical Co., Ltd.
11.23.1 Liaoning Deshan Pharmaceutical Co., Ltd. Corporation Information
11.23.2 Liaoning Deshan Pharmaceutical Co., Ltd. Business Overview
11.23.3 Liaoning Deshan Pharmaceutical Co., Ltd. Gastrodia Capsules Product Models, Descriptions and Specifications
11.23.4 Liaoning Deshan Pharmaceutical Co., Ltd. Gastrodia Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.23.5 Liaoning Deshan Pharmaceutical Co., Ltd. Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Gastrodia Capsules Industry Chain
12.2 Gastrodia Capsules Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Gastrodia Capsules Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Gastrodia Capsules Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Gastrodia Capsules Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Gastrodia Capsules Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Gastrodia Capsules Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Gastrodia Capsules Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Gastrodia Capsules Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Gastrodia Capsules Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Gastrodia Capsules Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Gastrodia Capsules Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Gastrodia Capsules Sales by Region (2020-2025) & (K Units)
 Table 8. Global Gastrodia Capsules Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Gastrodia Capsules Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Gastrodia Capsules Sales Share by Manufacturers (2020-2025)
 Table 12. Global Gastrodia Capsules Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Gastrodia Capsules Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Gastrodia Capsules by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrodia Capsules as of 2024)
 Table 16. Global Gastrodia Capsules Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Gastrodia Capsules Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Gastrodia Capsules Manufacturing Base and Headquarters
 Table 19. Global Gastrodia Capsules Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Gastrodia Capsules Sales by Type (2020-2025) & (K Units)
 Table 23. Global Gastrodia Capsules Sales by Type (2026-2031) & (K Units)
 Table 24. Global Gastrodia Capsules Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Gastrodia Capsules Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Gastrodia Capsules ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Gastrodia Capsules Sales by Application (2020-2025) & (K Units)
 Table 29. Global Gastrodia Capsules Sales by Application (2026-2031) & (K Units)
 Table 30. Gastrodia Capsules High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Gastrodia Capsules Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Gastrodia Capsules Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Gastrodia Capsules ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Gastrodia Capsules Growth Accelerators and Market Barriers
 Table 37. North America Gastrodia Capsules Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Gastrodia Capsules Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Gastrodia Capsules Growth Accelerators and Market Barriers
 Table 40. Europe Gastrodia Capsules Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Gastrodia Capsules Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Gastrodia Capsules Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Gastrodia Capsules Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Gastrodia Capsules Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Gastrodia Capsules Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Gastrodia Capsules Investment Opportunities and Key Challenges
 Table 47. Central and South America Gastrodia Capsules Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Gastrodia Capsules Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Gastrodia Capsules Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Hefei Jinyue Pharmaceutical Co., Ltd. Corporation Information
 Table 51. Hefei Jinyue Pharmaceutical Co., Ltd. Description and Major Businesses
 Table 52. Hefei Jinyue Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
 Table 53. Hefei Jinyue Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Hefei Jinyue Pharmaceutical Co., Ltd. Sales Value Proportion by Product in 2024
 Table 55. Hefei Jinyue Pharmaceutical Co., Ltd. Sales Value Proportion by Application in 2024
 Table 56. Hefei Jinyue Pharmaceutical Co., Ltd. Sales Value Proportion by Geographic Area in 2024
 Table 57. Hefei Jinyue Pharmaceutical Co., Ltd. Gastrodia Capsules SWOT Analysis
 Table 58. Hefei Jinyue Pharmaceutical Co., Ltd. Recent Developments
 Table 59. Tonghua Xindongri Pharmaceutical Co., Ltd. Corporation Information
 Table 60. Tonghua Xindongri Pharmaceutical Co., Ltd. Description and Major Businesses
 Table 61. Tonghua Xindongri Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
 Table 62. Tonghua Xindongri Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Tonghua Xindongri Pharmaceutical Co., Ltd. Sales Value Proportion by Product in 2024
 Table 64. Tonghua Xindongri Pharmaceutical Co., Ltd. Sales Value Proportion by Application in 2024
 Table 65. Tonghua Xindongri Pharmaceutical Co., Ltd. Sales Value Proportion by Geographic Area in 2024
 Table 66. Tonghua Xindongri Pharmaceutical Co., Ltd. Gastrodia Capsules SWOT Analysis
 Table 67. Tonghua Xindongri Pharmaceutical Co., Ltd. Recent Developments
 Table 68. Jilin Haitong Pharmaceutical Co., Ltd. Corporation Information
 Table 69. Jilin Haitong Pharmaceutical Co., Ltd. Description and Major Businesses
 Table 70. Jilin Haitong Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
 Table 71. Jilin Haitong Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Jilin Haitong Pharmaceutical Co., Ltd. Sales Value Proportion by Product in 2024
 Table 73. Jilin Haitong Pharmaceutical Co., Ltd. Sales Value Proportion by Application in 2024
 Table 74. Jilin Haitong Pharmaceutical Co., Ltd. Sales Value Proportion by Geographic Area in 2024
 Table 75. Jilin Haitong Pharmaceutical Co., Ltd. Gastrodia Capsules SWOT Analysis
 Table 76. Jilin Haitong Pharmaceutical Co., Ltd. Recent Developments
 Table 77. Jilin Jichun Pharmaceutical Co., Ltd. Corporation Information
 Table 78. Jilin Jichun Pharmaceutical Co., Ltd. Description and Major Businesses
 Table 79. Jilin Jichun Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
 Table 80. Jilin Jichun Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Jilin Jichun Pharmaceutical Co., Ltd. Sales Value Proportion by Product in 2024
 Table 82. Jilin Jichun Pharmaceutical Co., Ltd. Sales Value Proportion by Application in 2024
 Table 83. Jilin Jichun Pharmaceutical Co., Ltd. Sales Value Proportion by Geographic Area in 2024
 Table 84. Jilin Jichun Pharmaceutical Co., Ltd. Gastrodia Capsules SWOT Analysis
 Table 85. Jilin Jichun Pharmaceutical Co., Ltd. Recent Developments
 Table 86. Huatuo Sinopharm Co., Ltd. Corporation Information
 Table 87. Huatuo Sinopharm Co., Ltd. Description and Major Businesses
 Table 88. Huatuo Sinopharm Co., Ltd. Product Models, Descriptions and Specifications
 Table 89. Huatuo Sinopharm Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Huatuo Sinopharm Co., Ltd. Sales Value Proportion by Product in 2024
 Table 91. Huatuo Sinopharm Co., Ltd. Sales Value Proportion by Application in 2024
 Table 92. Huatuo Sinopharm Co., Ltd. Sales Value Proportion by Geographic Area in 2024
 Table 93. Huatuo Sinopharm Co., Ltd. Gastrodia Capsules SWOT Analysis
 Table 94. Huatuo Sinopharm Co., Ltd. Recent Developments
 Table 95. Tonghua Jitong Pharmaceutical Co., Ltd. Corporation Information
 Table 96. Tonghua Jitong Pharmaceutical Co., Ltd. Description and Major Businesses
 Table 97. Tonghua Jitong Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
 Table 98. Tonghua Jitong Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Tonghua Jitong Pharmaceutical Co., Ltd. Recent Developments
 Table 100. Tonghua Yongji Pharmaceutical Co., Ltd. Corporation Information
 Table 101. Tonghua Yongji Pharmaceutical Co., Ltd. Description and Major Businesses
 Table 102. Tonghua Yongji Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
 Table 103. Tonghua Yongji Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Tonghua Yongji Pharmaceutical Co., Ltd. Recent Developments
 Table 105. Tonghua Aixin Pharmaceutical Co., Ltd. Corporation Information
 Table 106. Tonghua Aixin Pharmaceutical Co., Ltd. Description and Major Businesses
 Table 107. Tonghua Aixin Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
 Table 108. Tonghua Aixin Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Tonghua Aixin Pharmaceutical Co., Ltd. Recent Developments
 Table 110. Changbaishan Pharmaceutical Co., Ltd. Corporation Information
 Table 111. Changbaishan Pharmaceutical Co., Ltd. Description and Major Businesses
 Table 112. Changbaishan Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
 Table 113. Changbaishan Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Changbaishan Pharmaceutical Co., Ltd. Recent Developments
 Table 115. Anshan Pharmaceutical Co., Ltd. Corporation Information
 Table 116. Anshan Pharmaceutical Co., Ltd. Description and Major Businesses
 Table 117. Anshan Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
 Table 118. Anshan Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Anshan Pharmaceutical Co., Ltd. Recent Developments
 Table 120. Revised Pharmaceutical Group Co., Ltd. Corporation Information
 Table 121. Revised Pharmaceutical Group Co., Ltd. Description and Major Businesses
 Table 122. Revised Pharmaceutical Group Co., Ltd. Product Models, Descriptions and Specifications
 Table 123. Revised Pharmaceutical Group Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Revised Pharmaceutical Group Co., Ltd. Recent Developments
 Table 125. Jilin Luwang Pharmaceutical Co., Ltd. Corporation Information
 Table 126. Jilin Luwang Pharmaceutical Co., Ltd. Description and Major Businesses
 Table 127. Jilin Luwang Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
 Table 128. Jilin Luwang Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. Jilin Luwang Pharmaceutical Co., Ltd. Recent Developments
 Table 130. Shanxi Wanglong Pharmaceutical Group Co., Ltd. Corporation Information
 Table 131. Shanxi Wanglong Pharmaceutical Group Co., Ltd. Description and Major Businesses
 Table 132. Shanxi Wanglong Pharmaceutical Group Co., Ltd. Product Models, Descriptions and Specifications
 Table 133. Shanxi Wanglong Pharmaceutical Group Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. Shanxi Wanglong Pharmaceutical Group Co., Ltd. Recent Developments
 Table 135. Suzhou Huabao Pharmaceutical Co., Ltd. Corporation Information
 Table 136. Suzhou Huabao Pharmaceutical Co., Ltd. Description and Major Businesses
 Table 137. Suzhou Huabao Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
 Table 138. Suzhou Huabao Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 139. Suzhou Huabao Pharmaceutical Co., Ltd. Recent Developments
 Table 140. Jilin Zixin Pharmaceutical Co., Ltd. Corporation Information
 Table 141. Jilin Zixin Pharmaceutical Co., Ltd. Description and Major Businesses
 Table 142. Jilin Zixin Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
 Table 143. Jilin Zixin Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 144. Jilin Zixin Pharmaceutical Co., Ltd. Recent Developments
 Table 145. Harbin Traditional Chinese Medicine No.4 Co., Ltd. Corporation Information
 Table 146. Harbin Traditional Chinese Medicine No.4 Co., Ltd. Description and Major Businesses
 Table 147. Harbin Traditional Chinese Medicine No.4 Co., Ltd. Product Models, Descriptions and Specifications
 Table 148. Harbin Traditional Chinese Medicine No.4 Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 149. Harbin Traditional Chinese Medicine No.4 Co., Ltd. Recent Developments
 Table 150. Jilin Changbaishan Pharmaceutical Group Co., Ltd. Corporation Information
 Table 151. Jilin Changbaishan Pharmaceutical Group Co., Ltd. Description and Major Businesses
 Table 152. Jilin Changbaishan Pharmaceutical Group Co., Ltd. Product Models, Descriptions and Specifications
 Table 153. Jilin Changbaishan Pharmaceutical Group Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 154. Jilin Changbaishan Pharmaceutical Group Co., Ltd. Recent Developments
 Table 155. Tonghua Dongsheng Pharmaceutical Co., Ltd. Corporation Information
 Table 156. Tonghua Dongsheng Pharmaceutical Co., Ltd. Description and Major Businesses
 Table 157. Tonghua Dongsheng Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
 Table 158. Tonghua Dongsheng Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 159. Tonghua Dongsheng Pharmaceutical Co., Ltd. Recent Developments
 Table 160. Yaodu Pharmaceutical Group Co., Ltd. Corporation Information
 Table 161. Yaodu Pharmaceutical Group Co., Ltd. Description and Major Businesses
 Table 162. Yaodu Pharmaceutical Group Co., Ltd. Product Models, Descriptions and Specifications
 Table 163. Yaodu Pharmaceutical Group Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 164. Yaodu Pharmaceutical Group Co., Ltd. Recent Developments
 Table 165. Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Corporation Information
 Table 166. Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Description and Major Businesses
 Table 167. Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Product Models, Descriptions and Specifications
 Table 168. Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 169. Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Recent Developments
 Table 170. Jilin Sinopharm Pharmaceutical Co., Ltd. Corporation Information
 Table 171. Jilin Sinopharm Pharmaceutical Co., Ltd. Description and Major Businesses
 Table 172. Jilin Sinopharm Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
 Table 173. Jilin Sinopharm Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 174. Jilin Sinopharm Pharmaceutical Co., Ltd. Recent Developments
 Table 175. Jilin Fusong Pharmaceutical Co., Ltd. Corporation Information
 Table 176. Jilin Fusong Pharmaceutical Co., Ltd. Description and Major Businesses
 Table 177. Jilin Fusong Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
 Table 178. Jilin Fusong Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 179. Jilin Fusong Pharmaceutical Co., Ltd. Recent Developments
 Table 180. Liaoning Deshan Pharmaceutical Co., Ltd. Corporation Information
 Table 181. Liaoning Deshan Pharmaceutical Co., Ltd. Description and Major Businesses
 Table 182. Liaoning Deshan Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
 Table 183. Liaoning Deshan Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 184. Liaoning Deshan Pharmaceutical Co., Ltd. Recent Developments
 Table 185. Key Raw Materials Distribution
 Table 186. Raw Materials Key Suppliers
 Table 187. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 188. Milestones in Production Technology Evolution
 Table 189. Distributors List
 Table 190. Market Trends and Market Evolution
 Table 191. Market Drivers and Opportunities
 Table 192. Market Challenges, Risks, and Restraints
 Table 193. Research Programs/Design for This Report
 Table 194. Key Data Information from Secondary Sources
 Table 195. Key Data Information from Primary Sources


List of Figures
 Figure 1. Gastrodia Capsules Product Picture
 Figure 2. Global Gastrodia Capsules Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. 0.25g Per Capsule Product Picture
 Figure 4. 0.5g Per Capsule Product Picture
 Figure 5. Global Gastrodia Capsules Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Hospital
 Figure 7. Clinic
 Figure 8. Others
 Figure 9. Gastrodia Capsules Report Years Considered
 Figure 10. Global Gastrodia Capsules Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Gastrodia Capsules Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Gastrodia Capsules Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Gastrodia Capsules Revenue Market Share by Region (2020-2031)
 Figure 14. Global Gastrodia Capsules Sales (2020-2031) & (K Units)
 Figure 15. Global Gastrodia Capsules Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 16. Global Gastrodia Capsules Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Gastrodia Capsules Sales Volume Market Share in 2024
 Figure 18. Global Gastrodia Capsules Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. 0.25g Per Capsule Revenue Market Share by Manufacturer in 2024
 Figure 21. 0.5g Per Capsule Revenue Market Share by Manufacturer in 2024
 Figure 22. Global Gastrodia Capsules Sales Market Share by Type (2020-2031)
 Figure 23. Global Gastrodia Capsules Revenue Market Share by Type (2020-2031)
 Figure 24. Global Gastrodia Capsules Sales Market Share by Application (2020-2031)
 Figure 25. Global Gastrodia Capsules Revenue Market Share by Application (2020-2031)
 Figure 26. North America Gastrodia Capsules Sales YoY (2020-2031) & (K Units)
 Figure 27. North America Gastrodia Capsules Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Manufacturers Gastrodia Capsules Sales Revenue (US$ Million) in 2024
 Figure 29. North America Gastrodia Capsules Sales Volume (K Units) by Type (2020- 2031)
 Figure 30. North America Gastrodia Capsules Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America Gastrodia Capsules Sales Volume (K Units) by Application (2020-2031)
 Figure 32. North America Gastrodia Capsules Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 33. US Gastrodia Capsules Revenue (2020-2031) & (US$ Million)
 Figure 34. Canada Gastrodia Capsules Revenue (2020-2031) & (US$ Million)
 Figure 35. Mexico Gastrodia Capsules Revenue (2020-2031) & (US$ Million)
 Figure 36. Europe Gastrodia Capsules Sales YoY (2020-2031) & (K Units)
 Figure 37. Europe Gastrodia Capsules Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Europe Top 5 Manufacturers Gastrodia Capsules Sales Revenue (US$ Million) in 2024
 Figure 39. Europe Gastrodia Capsules Sales Volume (K Units) by Type (2020-2031)
 Figure 40. Europe Gastrodia Capsules Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Europe Gastrodia Capsules Sales Volume (K Units) by Application (2020-2031)
 Figure 42. Europe Gastrodia Capsules Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Germany Gastrodia Capsules Revenue (2020-2031) & (US$ Million)
 Figure 44. France Gastrodia Capsules Revenue (2020-2031) & (US$ Million)
 Figure 45. U.K. Gastrodia Capsules Revenue (2020-2031) & (US$ Million)
 Figure 46. Italy Gastrodia Capsules Revenue (2020-2031) & (US$ Million)
 Figure 47. Russia Gastrodia Capsules Revenue (2020-2031) & (US$ Million)
 Figure 48. Asia-Pacific Gastrodia Capsules Sales YoY (2020-2031) & (K Units)
 Figure 49. Asia-Pacific Gastrodia Capsules Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Top 8 Manufacturers Gastrodia Capsules Sales Revenue (US$ Million) in 2024
 Figure 51. Asia-Pacific Gastrodia Capsules Sales Volume (K Units) by Type (2020- 2031)
 Figure 52. Asia-Pacific Gastrodia Capsules Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 53. Asia-Pacific Gastrodia Capsules Sales Volume (K Units) by Application (2020-2031)
 Figure 54. Asia-Pacific Gastrodia Capsules Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Indonesia Gastrodia Capsules Revenue (2020-2031) & (US$ Million)
 Figure 56. Japan Gastrodia Capsules Revenue (2020-2031) & (US$ Million)
 Figure 57. South Korea Gastrodia Capsules Revenue (2020-2031) & (US$ Million)
 Figure 58. China Taiwan Gastrodia Capsules Revenue (2020-2031) & (US$ Million)
 Figure 59. India Gastrodia Capsules Revenue (2020-2031) & (US$ Million)
 Figure 60. Central and South America Gastrodia Capsules Sales YoY (2020-2031) & (K Units)
 Figure 61. Central and South America Gastrodia Capsules Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Central and South America Top 5 Manufacturers Gastrodia Capsules Sales Revenue (US$ Million) in 2024
 Figure 63. Central and South America Gastrodia Capsules Sales Volume (K Units) by Type (2021-2031)
 Figure 64. Central and South America Gastrodia Capsules Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Central and South America Gastrodia Capsules Sales Volume (K Units) by Application (2020-2031)
 Figure 66. Central and South America Gastrodia Capsules Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Brazil Gastrodia Capsules Revenue (2020-2025) & (US$ Million)
 Figure 68. Argentina Gastrodia Capsules Revenue (2020-2025) & (US$ Million)
 Figure 69. Middle East, and Africa Gastrodia Capsules Sales YoY (2020-2031) & (K Units)
 Figure 70. Middle East and Africa Gastrodia Capsules Revenue YoY (2020-2031) & (US$ Million)
 Figure 71. Middle East and Africa Top 5 Manufacturers Gastrodia Capsules Sales Revenue (US$ Million) in 2024
 Figure 72. Middle East and Africa Gastrodia Capsules Sales Volume (K Units) by Type (2021-2031)
 Figure 73. South America Gastrodia Capsules Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 74. Middle East and Africa Gastrodia Capsules Sales Volume (K Units) by Application (2020-2031)
 Figure 75. Middle East and Africa Gastrodia Capsules Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 76. GCC Countries Gastrodia Capsules Revenue (2020-2025) & (US$ Million)
 Figure 77. Turkey Gastrodia Capsules Revenue (2020-2025) & (US$ Million)
 Figure 78. Egypt Gastrodia Capsules Revenue (2020-2025) & (US$ Million)
 Figure 79. South Africa Gastrodia Capsules Revenue (2020-2025) & (US$ Million)
 Figure 80. Gastrodia Capsules Industry Chain Mapping
 Figure 81. Regional Gastrodia Capsules Manufacturing Base Distribution (%)
 Figure 82. Global Gastrodia Capsules Production Market Share by Region (2020-2031)
 Figure 83. Gastrodia Capsules Production Process
 Figure 84. Regional Gastrodia Capsules Production Cost Structure
 Figure 85. Channels of Distribution (Direct Vs Distribution)
 Figure 86. Bottom-up and Top-down Approaches for This Report
 Figure 87. Data Triangulation
 Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network